A critical advance in cancer research is occurring with the use of nanobodies to restore mutated p53. This essential malignant suppressor protein is frequently inactivated in several forms of malignancies, leading https://seolistlinks.com/story23515656/mini-antibodies-revive-tumor-suppressor-p53-a-promising-pathway-for-tumor-therapy